These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 9069535

  • 1. Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
    Péchinot A, Neuwirth C, Bryskier A, Duez JM, Kazmierczak A.
    J Antimicrob Chemother; 1997 Feb; 39(2):157-62. PubMed ID: 9069535
    [Abstract] [Full Text] [Related]

  • 2. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of cefodizime.
    Knothe H, Shah PM.
    Infection; 1992 May; 20 Suppl 1():S3-8. PubMed ID: 1526673
    [Abstract] [Full Text] [Related]

  • 4. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G, Milazzo I, Musumeci R, Nicolosi VM, Speciale A, Nicoletti G.
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro activity of cefodizime: a review.
    Soussy CJ, Chanal M, Kitzis MD.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():13-21. PubMed ID: 2074248
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of cefodizime (HR-221).
    Ahonkhai VI, Cherubin CE, Shulman MA.
    Antimicrob Agents Chemother; 1982 Oct; 22(4):715-8. PubMed ID: 6295264
    [Abstract] [Full Text] [Related]

  • 7. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
    Pruksachatvuthi S, Aswapokee N, Aswapokee P.
    J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V, Nicolas MH, Philippon A, Giroir AM, Grosset J.
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [Abstract] [Full Text] [Related]

  • 9. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
    Jones RN, Barry AL, Thornsberry C, Wilson HW.
    Antimicrob Agents Chemother; 1981 Dec; 20(6):760-8. PubMed ID: 6275785
    [Abstract] [Full Text] [Related]

  • 10. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y, Ishihara R, Ishii Y, Nakazawa A, Deguchi K, Matsumoto Y, Nishinari C, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [Abstract] [Full Text] [Related]

  • 11. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO, Bryskier A, Izard D, Leclerc H.
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [Abstract] [Full Text] [Related]

  • 12. [Antimicrobial activity of cefodizime against fresh clinical isolates].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Suzuki K.
    Jpn J Antibiot; 1993 Oct; 46(10):860-76. PubMed ID: 8254888
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995 Oct; 41(4):267-75. PubMed ID: 7555207
    [Abstract] [Full Text] [Related]

  • 14. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ, Traynor EA.
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [Abstract] [Full Text] [Related]

  • 15. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
    Rolin O, Roche G, Bouanchaud DH.
    Presse Med; 1989 Oct 11; 18(32):1569-71. PubMed ID: 2530534
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of cephalosporins by beta-lactamases of gram-negative rods.
    Bauernfeind A, Petermüller C, Jungwirth R.
    Infection; 1983 Oct 11; 11 Suppl 1():S39-43. PubMed ID: 6339417
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995 Oct 11; 41(3):178-86. PubMed ID: 7656663
    [Abstract] [Full Text] [Related]

  • 18. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ, Otterbein G, Le Van Thoi J, Duval J, Chanal M, Cluzel M, Sirot D.
    Pathol Biol (Paris); 1986 Jun 11; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [Abstract] [Full Text] [Related]

  • 19. Inducing capacity and selection of resistant variants of cefpirome (HR 810) in comparison with other beta-lactam compounds.
    Stobberingh EE, Houben AW.
    Chemotherapy; 1988 Jun 11; 34(6):490-6. PubMed ID: 3072153
    [Abstract] [Full Text] [Related]

  • 20. [Synergistic action of cefodizime with other antimicrobial agents on clinically isolated microorganisms. II. Synergistic action with sisomicin].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1992 Jan 11; 45(1):1-11. PubMed ID: 1495193
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.